Please use this identifier to cite or link to this item:
https://hdl.handle.net/2440/120700
Citations | ||
Scopus | Web of Science® | Altmetric |
---|---|---|
?
|
?
|
Type: | Journal article |
Title: | Modeling the safe minimum frequency of molecular monitoring for CML patients attempting treatment-free remission |
Author: | Shanmuganathan, N. Braley, J.A. Yong, A.S.M. Hiwase, D.K. Yeung, D.T. Ross, D.M. Hughes, T.P. Branford, S. |
Citation: | Blood, 2019; 134(1):85-89 |
Publisher: | American Society of Hematology |
Issue Date: | 2019 |
ISSN: | 0006-4971 1528-0020 |
Statement of Responsibility: | Naranie Shanmuganathan, Jodi A. Braley, Agnes S. M. Yong, Devendra K. Hiwase, David T. Yeung, David M. Ross, Timothy P. Hughes and Susan Branford |
Abstract: | Abstract not available |
Keywords: | Humans Neoplasm Recurrence, Local Fusion Proteins, bcr-abl Antineoplastic Agents Protein Kinase Inhibitors Remission Induction Algorithms Leukemia, Myelogenous, Chronic, BCR-ABL Positive Genetic Testing |
Rights: | © The American Society of Hematology |
DOI: | 10.1182/blood.2019000120 |
Grant ID: | http://purl.org/au-research/grants/nhmrc/1104425 http://purl.org/au-research/grants/nhmrc/1135949 |
Published version: | http://dx.doi.org/10.1182/blood.2019000120 |
Appears in Collections: | Aurora harvest 8 Medicine publications |
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.